Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Clinical trial NCT07081984 · RECRUITING

Trial details

NCT number: NCT07081984
Sponsor: Therorna
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HPV 16+ Recurrent or Metastatic Cancer HNSCC Cervical Cancer

Start date: 2025-11-11
Primary completion: 2026-09-20
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.